MONTREAL, Jan. 30, 2023 /CNW Telbec/ - Valeo Pharma Inc. (CNSX:VPH.CN) (OTC-BB:VPHIF) (FSE:VP2) ("Valeo" or the "Company"), a fast-growing Canadian pharmaceutical company, today reported its financial results for the fourth quarter and year-ended October 31, 2022.
Read more at newswire.caVALEO PHARMA REPORTS RECORD QUARTERLY AND ANNUAL REVENUES FOR THE FOURTH QUARTER AND THE FISCAL YEAR 2022
Newswire.ca - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
/Broadcom%20Inc%20HQ%20photo-by%20Sundry%20Photogrpahy%20via%20iStock.jpg)
/Super%20Micro%20Computer%20Inc%20logo%20on%20building-by%20Poetra_RH%20via%20Shutterstock.jpg)
/Intel%20Corp_%20Santa%20Clara%20campus-by%20jejim%20via%20Shutterstock.jpg)
/Apple%20Inc%20Tim%20Cook-by%20John%20Gress%20Media%20Inc%20via%20Shutterstock.jpg)